TVTX logo

Travere Therapeutics (TVTX) Working capital

annual working capital:

$215.95M-$222.92M(-50.79%)
December 31, 2024

Summary

  • As of today (July 1, 2025), TVTX annual working capital is $215.95 million, with the most recent change of -$222.92 million (-50.79%) on December 31, 2024.
  • During the last 3 years, TVTX annual working capital has fallen by -$242.79 million (-52.93%).
  • TVTX annual working capital is now -52.93% below its all-time high of $458.74 million, reached on December 31, 2021.

Performance

TVTX Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

quarterly working capital:

$191.71M-$24.24M(-11.22%)
March 31, 2025

Summary

  • As of today (July 1, 2025), TVTX quarterly working capital is $191.71 million, with the most recent change of -$24.24 million (-11.22%) on March 31, 2025.
  • Over the past year, TVTX quarterly working capital has dropped by -$116.13 million (-37.72%).
  • TVTX quarterly working capital is now -64.94% below its all-time high of $546.80 million, reached on September 30, 2023.

Performance

TVTX quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

TVTX Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-50.8%-37.7%
3 y3 years-52.9%-62.5%
5 y5 years-35.3%-43.4%

TVTX Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-52.9%at low-64.9%+42.3%
5 y5-year-52.9%at low-64.9%+42.3%
alltimeall time-52.9%+407.6%-64.9%+279.2%

TVTX Working capital History

DateAnnualQuarterly
Mar 2025
-
$191.71M(-11.2%)
Dec 2024
$215.95M(-50.8%)
$215.95M(+60.3%)
Sep 2024
-
$134.70M(-45.6%)
Jun 2024
-
$247.71M(-19.5%)
Mar 2024
-
$307.85M(-29.9%)
Dec 2023
$438.87M(+27.5%)
$438.87M(-19.7%)
Sep 2023
-
$546.80M(+34.6%)
Jun 2023
-
$406.34M(-14.3%)
Mar 2023
-
$474.26M(+37.8%)
Dec 2022
$344.27M(-25.0%)
$344.27M(-14.7%)
Sep 2022
-
$403.81M(-12.6%)
Jun 2022
-
$462.29M(-9.6%)
Mar 2022
-
$511.62M(+11.5%)
Dec 2021
$458.74M(+44.4%)
$458.74M(-1.5%)
Sep 2021
-
$465.92M(+2.9%)
Jun 2021
-
$452.82M(-5.7%)
Mar 2021
-
$480.03M(+51.1%)
Dec 2020
$317.75M(-4.8%)
$317.75M(-24.8%)
Sep 2020
-
$422.26M(-3.1%)
Jun 2020
-
$435.63M(+28.7%)
Mar 2020
-
$338.54M(+1.5%)
Dec 2019
$333.62M(-14.7%)
$333.62M(-5.1%)
Sep 2019
-
$351.70M(-4.0%)
Jun 2019
-
$366.43M(-1.3%)
Mar 2019
-
$371.44M(-5.0%)
Dec 2018
$391.06M(+62.8%)
$391.06M(-3.0%)
Sep 2018
-
$403.12M(+129.8%)
Jun 2018
-
$175.42M(-23.8%)
Mar 2018
-
$230.28M(-4.1%)
DateAnnualQuarterly
Dec 2017
$240.14M(-3.6%)
$240.14M(-0.5%)
Sep 2017
-
$241.44M(+0.6%)
Jun 2017
-
$240.03M(-2.4%)
Mar 2017
-
$245.84M(-1.3%)
Dec 2016
$249.09M(+15.9%)
$249.09M(-2.9%)
Sep 2016
-
$256.60M(+16.6%)
Jun 2016
-
$220.09M(-4.8%)
Mar 2016
-
$231.12M(+7.5%)
Dec 2015
$214.95M(-406.2%)
$214.95M(+8.6%)
Sep 2015
-
$198.01M(+173.7%)
Jun 2015
-
$72.36M(-44.9%)
Mar 2015
-
$131.38M(-287.1%)
Dec 2014
-$70.20M(+141.6%)
-$70.20M(+1802.4%)
Sep 2014
-
-$3.69M(-168.2%)
Jun 2014
-
$5.41M(-105.1%)
Mar 2014
-
-$107.00M(+268.2%)
Dec 2013
-$29.06M(+404.1%)
-$29.06M(+181.6%)
Sep 2013
-
-$10.32M(-3.8%)
Jun 2013
-
-$10.73M(-853.8%)
Mar 2013
-
$1.42M(-2295.8%)
Dec 2012
-$5.77M(+9037.7%)
-
Nov 2012
-
-$64.80K(+1.1%)
Aug 2012
-
-$64.10K(+0.8%)
May 2012
-
-$63.60K(+0.8%)
Feb 2012
-
-$63.10K(+2.1%)
Feb 2012
-$63.10K(+4.8%)
-
Nov 2011
-
-$61.80K(+70.2%)
Aug 2011
-
-$36.30K(-39.7%)
Feb 2011
-$60.20K
-$60.20K

FAQ

  • What is Travere Therapeutics annual working capital?
  • What is the all time high annual working capital for Travere Therapeutics?
  • What is Travere Therapeutics annual working capital year-on-year change?
  • What is Travere Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Travere Therapeutics?
  • What is Travere Therapeutics quarterly working capital year-on-year change?

What is Travere Therapeutics annual working capital?

The current annual working capital of TVTX is $215.95M

What is the all time high annual working capital for Travere Therapeutics?

Travere Therapeutics all-time high annual working capital is $458.74M

What is Travere Therapeutics annual working capital year-on-year change?

Over the past year, TVTX annual working capital has changed by -$222.92M (-50.79%)

What is Travere Therapeutics quarterly working capital?

The current quarterly working capital of TVTX is $191.71M

What is the all time high quarterly working capital for Travere Therapeutics?

Travere Therapeutics all-time high quarterly working capital is $546.80M

What is Travere Therapeutics quarterly working capital year-on-year change?

Over the past year, TVTX quarterly working capital has changed by -$116.13M (-37.72%)
On this page